Professor Marry Van den Heuvel-Eibrink MD, PhD is a Professor Pediatric Oncology and Senior Consultant Pediatric Oncology at Princis Maxima Centre, Utrecht. From 1997-2014 she was a Senior Consultant in Pediatric Oncology and Hematology at Erasmus MC-Sophia Children’s Hospital. Working Group leader of the ‘Erasmus MC Postgraduate Molecular Medicine School’ which is recognized by the Dutch Royal Academy of Science and Arts, since 2009. She has been Chair of the international EWOG-MDS foundation (2007-2017), and member of the international IBFM AML study Group (2000-2018). She is co-chair of the international renal tumor disease committee (SIOP-RTSG). She is of the national DCOG renal tumor committee and steering committee member of the chair DCOG late effects consortium. She has published over 350 international peer reviewed manuscripts and (co-)supervised 21 finalized and 15 ongoing PhD projects. She is since 2015, working in the Princess Maxima Center for Pediatric Oncology, where she has set up the Late effects clinic and where she focusses on and is responsible for the now established centralized care and translational research program for all children with renal tumors and as well as research regarding the identification of (genetic) determinants direct and late childhood cancer related toxicity.
Dedicated to translational research in pediatric oncology, with a special focus on renal tumors and the (genetic) variation of early and late toxicity of childhood cancer.